Neurogene's total assets for Q3 2024 were $164.12M, a decrease of -8.73% from the previous quarter. NGNE total liabilities were $26.71M for the fiscal quarter, a 7.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.